The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover

Featured
Interviews

Eye on China

Columns

Conferences ListingConferences
Listing

e-alerts
Pharma Sales
BIOBOARD - EUROPE
Inactivated polio vaccines broadly available for the world's children in the drive toward polio eradication

Sanofi Pasteur, the vaccines division of Sanofi has further commited to the international community's efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet global needs, announced it will purchase significant quantities of Inactivated Polio Vaccine (IPV) from Sanofi Pasteur and make it available based on country needs and vaccination plans. To achieve the goal of polio eradication by 2018, the World Health Organization (WHO) recommends that by end 2015, all children receive routinely at least one dose of IPV in over 120 countries that solely use Oral Polio Vaccine.

In order to support rapid and widespread adoption of IPV, Sanofi Pasteur — the world's largest producer of IPV — and the Bill & Melinda Gates Foundation have developed a joint price support mechanism, including a financial contribution from both organizations. This mechanism allows Sanofi Pasteur to offer IPV at a price of EUR 0.75 per dose (approximately US$1) to 73 of the world's poorest countries. The GAVI Alliance, a global immunization partnership, will make IPV available for inclusion in routine immunization schedules in these countries.

This announcement underscores Sanofi Pasteur's commitment to offer unparalleled volumes of high-quality IPV across a broad range of countries and economic situations at differential prices in an unprecedented, global rollout.

Source: PR Newswire

Click here for the complete issue.